3 completed. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
Follow 2 drug dose - DA: new trials by email Literature Review of 2 drug dose - DA trials Research Report on 2 drug dose - DA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis 2 drug dose - DA, 3 drug dose - IDA - Lymphatic Filariases | Completed | Washington University School of Medicine | 20092 | 2017-10-18 | 2020-12-31 | |
| Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji 3 drug dose - IDA, 3 drug dose - IDA with second dose of ivermectin, 2 drug dose - DA - Lymphatic Filariases, Scabies | Not applicable | Completed | Washington University School of Medicine | 4773 | 2017-07-13 | 2020-12-31 |
| Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis 3 drug dose - IDA, 2 drug dose - DA - Lymphatic Filariasis | Not applicable | Completed | Washington University School of Medicine | 23789 | 2016-07-01 | 2020-12-31 |
Elephantiasis, Filarial (3) · Impetigo (1) · Scabies (1)
Washington University School of Medicine (3)
Fiji (2) · Haiti (2) · India (2) · Indonesia (2) · Papua New Guinea (2)
Gary Weil, MD (3) · Andrew Steer, PhD (1) · Christopher King, MD PHD (1) · Christopher King, MD PhD (1)
PMID 35533701, PMID 31233507, PMID 33728462, PMID 33780481, PMID 34758017, PMID 35139070